Thus, our data reveal that the tumor-suppressive functions of Ezh2 are to maintain repression of a small number of oncogenes, including Plag1 and potentially Lin28b, which, upon derepression, contribute to more rapid AML development (Fig. 5 i). The gene discussed is EZH2; the disease is acute myeloid leukemia.